Preparation of Water-Soluble Solid Forms Containing Ursolic Acid Using Supercritical Fluid |
Lee, Sang-Yun
(Department of Chemical and Biochemical Engineering, The University of Suwon)
Jung, Ju-Hee (Department of Chemical and Biochemical Engineering, The University of Suwon) Jung, In-Il (Department of Chemical and Biochemical Engineering, The University of Suwon) Choi, Moon-Jae (Nebion Co., Ltd.) Park, Eui-Hoon (Nebion Co., Ltd.) Ryu, Jong-Hoon (Department of Chemical and Biochemical Engineering, The University of Suwon) Lim, Gio-Bin (Department of Chemical and Biochemical Engineering, The University of Suwon) |
1 | Ohigashi, H., Takamura, H., Koshimizu, K., Tokuda, H., and Y. Ito (1986), Cancer Lett. 30, 143-151 DOI ScienceOn |
2 | Foster, N. R, Ng, A. S., Dehghani, F., and H. L. Regtop (2003), Micronisation of tobramycin using dense gas anti-solvent techniques, In: Proc. 6th Int. Symp. Supercrit, Fluid 3, 1647-1652 |
3 | Suzuki, et al. (1994), Water-soluble pentacyclic triterpene composition and method for producing the same, US Patent, 5314877 |
4 | Jie Liu (2005), Oleanolic acid and ursolic acid: Research perspectives, J. Ethnophamacology 100, 92-94 DOI ScienceOn |
5 | Badawy, S. I. F., M. M., Ghorab, and C. M., Adeyeye (1996), Characterization and bioavailability of danazol-hydroxypropyl -cyclodextrin coprecipitates, Int. J. Pharm. 128, 45-54 DOI ScienceOn |
6 | Tokuda, H., Ohigashi, H., Koshimizu, K., and Y. Ito (1986), Cancer Lett. 33, 279-285 DOI ScienceOn |
7 | Foster, N. R, Meure, L. A., Barrett, A. M., Abbasi, F., and F. Dehghani (2003), Micronisation of griseofulvin by the aerosol solvent extraction system, In: Proc 6th Int. Symp. Supercrit, Fluid 3, 1771-1776 |
8 | Sohn, K. H., Lee, H. Y., Chung, H. Y., Young, H. S., Yi, S. Y. and K. W. Kim (1995), Cancer Lett. 94, 213-218 DOI ScienceOn |
9 | Charoenchaitrakool, M., F. Dehghani, and N. R Foster (2002), Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl--cyclodextrin, Int. J. Pharm. 239, 103-112 DOI ScienceOn |
10 | Huang, M. T., Ho, C. T., Wang, Z. Y., Ferraro, T., Lou, Y. R., Stauber, K., Ma, W., Georgiadis, C., Laskin, J. D., and A. H. Conney (1994), Cancer Res. 54, 701-708 |
11 | Siempmann, J. and N. A. Peppas (2001), Modelling of drug release from delivery systems based on hydroxypropyl mcthylccllulose, Adv. Drug Del. Rev. 48, 139-157 DOI ScienceOn |
12 | Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R, and W. E. Rudzinski (2001), Biodegradable polymeric nanoparticles as drug delivery devices, J. Control Release 70, 1-20 DOI ScienceOn |
13 | Jung J. and M. Perrut (2001), Particle design using supercritical fluids: literature and patent survey, J. Supercrit: Fluids 20, 179-219 DOI ScienceOn |
14 | Chattopadhyay, P. and R B. Gupta (2002), Supercritical CO_2, based production of magnetically responsive micro- and nanoparticles for drug targeting, Ind. Eng. Chem. Res. 41, 6049-6058 DOI ScienceOn |
15 | Foster, N., R, Dehghani, F., Bustami, R. T., and H. K. Chan (2003), Generation of lysozyme-lactose powders using the ASES process, In: Proc 6th Int. Symp Supercrit, Fluid 3, 1831-1836 |
16 | De Gioannis, B., Patrick, J., and P. Subra (2004), Morphology and growth control of griseofulvin recrystallised by compressed carbon dioxide as antisolvent, J. Crystal. Growth 262, 519-526 DOI ScienceOn |
17 | Mingqua G., et al. (2003), Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry, J. Mass Spectrom. 38, 723-731 DOI ScienceOn |
18 | Lee, Y. W., Lee, j. W., and J. S. Lim (2003), The formation of aspirin micro particulate using supercritical as solvent and antisolvent, In: Proc 6th Int. Symp. Supercrit, Fluid 3, 1777-1782 |
19 | Badawy, S. I. F., M. M. Ghorab, and C. M. Adeyeye (1996), Bioavailability of danazol-hydroxypropyl--cyclodextrin complex by different routes of administration, Int. J. Pharm. 145, 137-143 DOI ScienceOn |
20 | Badawy, S. I. F., A. L. Marshall, M. M. Ghorab, and C. M. Adeyeye (1996), A study of the complexation between danazol and hydrophilic cyclodextrin derivatives, Drug Dev. Ind. Pharm. 22, 959-966 DOI |